Cochlear Ltd. (ASX:COH) today launched its Nucleus 7 sound processor cochlear implant, touting it as the smallest and lightest behind-the-ear implant sound processor available. The Sydney-based company said that the newly launched Nucleus 7, which won FDA clearance last month, is the 1st cochlear implant designed to connect directly with Apple (NSDQ:AAPL) iOS devices, allowing individuals to stream […]
Otolaryngology/Ear, Nose & Throat (ENT)
Entellus Medical inks $81m deal for Spirox
Entellus Medical (NSDQ:ENTL) said today that it inked a deal worth some $81 million to acquire Spirox and its Latera absorbable nasal implant. The deal calls for Entellus to pay $25 million in cash and 3.4 million shares of its own stock for Redwood City, Calif.-based Spirox, which won 510(k) clearance from the FDA for the Latera […]
Google backs Decibel Therapeutics in big data hearing loss play
Decibel Therapeutics said today it landed an investment from GV, formerly Google Ventures. GV agreed to make an equity investment in the Boston-based company and lend its capabilities in big data sciences and analytics to Decibel’s efforts in developing therapies for hearing loss and tinnitus. Get the full story at our sister site, Drug Delivery Business […]
6 surgical robots that will surprise you
Researchers around the globe have created surgical robots for solutions to procedures that are generally invasive and time-consuming. Whether its eye surgery or even finding a vein to draw blood, healthcare practitioners face daunting tasks, but robots have made these procedures easier (as easy as the DaVinci makes it look when peeling a grape and […]
Cochlear shares jump on FDA nod for Nucleus 7 sound processor
Hearing implant maker Cochlear Ltd. (ASX:COH) has seen shares rise nearly 4% after the company won FDA approval for its Nucleus 7 sound processor, according to a Motley Fool Australia report. The newly cleared N7 processor is superior to its prior N6 version, and is compatible with Apple’s iOS, while its telecoil is optimized for loops, according […]
Earlens closes $118m in mixed debt and equity round
Earlens said today it closed a total of $118 million in funding, with $73 million coming from an offering of Series C preferred stock and $45 from a structured debt facility with CRG LP. The Earlens device, which won 510(k) clearance from the FDA in October 2015, uses a laser diode attached to a behind-the-ear audio processor […]
Torax Medical touts preliminary results from Linx GERD study
Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon‘s Torax Medical business today released results from the Caliber trial of its Linx system for treating gastro-esophageal reflux disease, touting quality of life improvements and reduction in reflux levels. The Linx system is an implant composed of interlinked titanium beads with magnetic cores that augments the esophageal sphincter’s barrier […]
Intersect ENT updates on Sinuva steroid-releasing sinus implant
Intersect ENT (NSDQ:XENT) said today that the FDA is slated to make a decision on its new drug application for the Sinuva steroid-releasing sinus implant by January 7, 2018. The Sinuva implant, which was previously called the Resolve implant, is placed during an in-office doctors appointment and is designed to be a treatment option for […]
Spirox touts 1-year 1st-in-human study results of Latera nasal implant
Spirox today released 1-year data from the 1st-in-human study of its Latera absorbable nasal implant designed to support nasal cartilage and prevent nasal valve collapse, which can contribute to nasal obstruction. Results from the study were published in the April issue of the journal Facial Plastic Surgery. Data from the study indicated that patients treated […]
Ethicon closes Torax Medical buy
Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon said today it closed its acquisition of Torax Medical, and its Linx acid reflux treatment portfolio, for an undisclosed amount. The Linx system from Shoreview, Minn.-based Torax is an implant composed of interlinked titanium beads with magnetic cores that augments the esophageal sphincter’s barrier function to prevent reflux in patients […]
Intersect ENT seeks FDA nod for Resolve steroid-releasing implant
Intersect ENT (NSDQ:XENT) said today that it submitted a New Drug Application to the FDA for its Resolve steroid-releasing implant to treat chronic sinusitis patients with recurrent sinus obstruction. The Menlo Park, Calif.-based company’s implant can be placed during a routine physician office visit and is designed to be a less invasive treatment option for recurrent […]